Cargando…
Case Report: Treatment of Hypertrophic Cardiomyopathy With Stereotactic Body Radiotherapy
Patients with hypertrophic cardiomyopathy (HCM), which is characterized by left ventricular hypertrophy, is usually treated with medications such as calcium channel blockers or beta-blockers and invasive treatments such as transcatheter alcohol septal ablation, percutaneous radiofrequency ablation,...
Autores principales: | Xiao, Longzihui, Liu, Jiayi, Zhang, Yingzhe, Liu, Yuefei, Tang, Yan, Zhang, Minping, Ding, Zhuyuan, Xiao, Enhua, Chen, Taili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198300/ https://www.ncbi.nlm.nih.gov/pubmed/35721064 http://dx.doi.org/10.3389/fmed.2022.799310 |
Ejemplares similares
-
Retraction: Case report: Treatment of hypertrophic cardiomyopathy with stereotactic body radiotherapy
Publicado: (2023) -
Body composition and mortality in a cohort study of Chinese patients with hypertrophic cardiomyopathy
por: Zhou, Ke, et al.
Publicado: (2023) -
The Involvement of ALPK3 in Hypertrophic Cardiomyopathy in East Asia
por: Dai, Jiaqi, et al.
Publicado: (2022) -
Hypertrophic Obstructive Cardiomyopathy: Comparison of Outcomes After Myectomy or Alcohol Ablation
por: Meng, Xiangbin, et al.
Publicado: (2022) -
Orthotopic Versus Allotopic Implantation: Comparison of Radiological and Pathological Characteristics
por: Cai, YeYu, et al.
Publicado: (2021)